|
DK590288D0
(da)
|
1988-10-24 |
1988-10-24 |
Symbicom Ab |
Kemiske forbindelser
|
|
AU530410B2
(en)
|
1978-02-21 |
1983-07-14 |
Sintef |
Preparing aqueous emulsions
|
|
US4281061A
(en)
|
1979-07-27 |
1981-07-28 |
Syva Company |
Double antibody for enhanced sensitivity in immunoassay
|
|
US4387164A
(en)
|
1980-11-05 |
1983-06-07 |
Fmc Corporation |
Method and apparatus for chemical analysis using reactive reagents dispersed in soluble film
|
|
NO155316C
(no)
|
1982-04-23 |
1987-03-11 |
Sintef |
Fremgangsmaate for fremstilling av magnetiske polymerpartikler.
|
|
US4876190A
(en)
|
1987-10-21 |
1989-10-24 |
Becton Dickinson & Company |
Peridinin-chlorophyll complex as fluorescent label
|
|
US5039487A
(en)
|
1987-12-22 |
1991-08-13 |
Board Of Regents, The University Of Texas System |
Methods for quantifying components in liquid samples
|
|
ATE130197T1
(de)
|
1988-06-14 |
1995-12-15 |
Cell Med Inc |
Heterofunktionelle zellular immunologische reagenzien, impfstoffe daraus und verwendungsverfahren.
|
|
US5260422A
(en)
|
1988-06-23 |
1993-11-09 |
Anergen, Inc. |
MHC conjugates useful in ameliorating autoimmunity
|
|
US6106840A
(en)
|
1988-06-23 |
2000-08-22 |
Anergen, Inc. |
MHC conjugates useful in ameliorating autoimmunity
|
|
US5468481A
(en)
|
1988-06-23 |
1995-11-21 |
Amergen, Inc. |
MHC class II-peptide conjugates useful in ameliorating autoimmunity
|
|
US5130297A
(en)
|
1988-06-23 |
1992-07-14 |
Anergen, Inc. |
Conjugates useful in ameliorating autoimmunity MHC-II-peptide
|
|
US5194425A
(en)
|
1988-06-23 |
1993-03-16 |
Anergen, Inc. |
Mhc-mediated toxic conjugates useful in ameliorating autoimmunity
|
|
DE3825615A1
(de)
|
1988-07-28 |
1990-02-01 |
Behringwerke Ag |
Antigenkonstrukte von "major histocompatibility complex" klasse i antigenen mit spezifischen traegermolekuelen, ihre herstellung und verwendung
|
|
DE4015911A1
(de)
|
1989-09-19 |
1991-03-28 |
Max Planck Gesellschaft |
Impfstoff gegen die lyme-krankheit
|
|
ES2092560T5
(es)
|
1989-12-22 |
2004-09-16 |
Mikrogen Molekularbiologische Entwicklungs-Gmbh |
Proteinas inmunologicamente activas de borrelia burgdorferi, estuches de ensayo relacionados y vacuna.
|
|
GB9007966D0
(en)
|
1990-04-09 |
1990-06-06 |
Dynal As |
Antigen/anti-antigen cleavage
|
|
SG122738A1
(en)
|
1990-06-15 |
2006-06-29 |
Univ Yale |
Compositions and methods for the prevention and diagnosis of lyme disease
|
|
IE76732B1
(en)
|
1990-08-07 |
1997-11-05 |
Becton Dickinson Co |
One step test for absolute counts
|
|
WO1994011078A1
(en)
|
1992-11-16 |
1994-05-26 |
Immunivest Corporation |
Magnetic immobilization and manipulation of biological entities
|
|
WO1992008983A1
(en)
|
1990-11-19 |
1992-05-29 |
Queen's University At Kingston |
Hiv marker/aids vaccine
|
|
US6129916A
(en)
|
1991-04-19 |
2000-10-10 |
Tanox, Inc. |
Method of Increasing activation on proliferation of T cells using antibody-microbead conjugates
|
|
CA2065658A1
(en)
|
1991-04-19 |
1992-10-20 |
Tse-Wen Chang |
Conjugates of liposomes or microbeads and antibodies specific for t lymphocytes and their use in vivo immune modulators
|
|
EP0630255B1
(en)
|
1991-04-23 |
2002-12-18 |
Anergen, Inc. |
Mhc conjugates useful in ameliorating autoimmunity
|
|
WO1992021972A1
(en)
|
1991-06-06 |
1992-12-10 |
Immulogic Pharmaceutical Corporation |
Rapid screening assay for the identification of ligand-receptor interactions
|
|
AU667051B2
(en)
|
1991-07-04 |
1996-03-07 |
Dako Denmark A/S |
Water-soluble, polymer-based reagents and conjugates comprising moieties derived from divinyl sulfone
|
|
US6872550B1
(en)
|
1991-07-11 |
2005-03-29 |
Baxter Vaccine Ag |
Immunogenic formulation of OspC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens
|
|
EP0598816B1
(en)
|
1991-08-15 |
1999-06-23 |
SMITHKLINE BEECHAM BIOLOGICALS s.a. |
Osp a proteins of borrelia burgdorferi subgroups, encoding genes and vaccines
|
|
ES2194010T3
(es)
|
1991-10-22 |
2003-11-16 |
Symbicom Ab |
Mejoras en el diagnostico y profilaxis de la borrelia burgdorferi.
|
|
WO1993010220A1
(en)
|
1991-11-19 |
1993-05-27 |
Anergen, Inc. |
Soluble mhc molecules and their uses
|
|
US5583031A
(en)
|
1992-02-06 |
1996-12-10 |
President And Fellows Of Harvard College |
Empty major histocompatibility class II heterodimers
|
|
EP0625910B1
(en)
|
1992-02-11 |
2003-07-23 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Dual carrier immunogenic construct
|
|
JP3167415B2
(ja)
|
1992-04-30 |
2001-05-21 |
オリンパス光学工業株式会社 |
固相免疫検査における抗原細胞の保存方法
|
|
DE69332268T2
(de)
|
1992-10-15 |
2003-08-14 |
Toray Industries, Inc. |
Verfahren zur herstellung von rekombinant mhcii protein in mikroorganismen
|
|
ES2191677T3
(es)
|
1992-10-21 |
2003-09-16 |
Stefan Miltenyi |
Seleccion directa de celulas mediante un producto de secrecion.
|
|
WO1994012196A1
(en)
|
1992-11-25 |
1994-06-09 |
Tanox Biosystems, Inc. |
Conjugates and constructs including anti-cd28 and anti-cd3 binding molecules
|
|
US6090587A
(en)
|
1993-10-25 |
2000-07-18 |
Corixa Corporation |
Prokaryotic expression of MHC proteins
|
|
EP0725838A4
(en)
|
1993-10-26 |
1997-02-26 |
United Biomedical Inc |
STRUCTURED SYNTHETIC ANTIGAN BANKS AS DIAGNOSTICS, VACCINE AND THERAPEUTIC AGENTS
|
|
AU8127494A
(en)
|
1993-11-01 |
1995-05-23 |
Associated Universities, Inc. |
Chimeric proteins comprising borrelia polypeptides: uses therefor
|
|
WO2002016422A2
(en)
|
2000-08-18 |
2002-02-28 |
Research Foundation Of The State University Of New York |
Recombinant constructs of borrelia burgdorferi
|
|
US5620862A
(en)
|
1993-11-24 |
1997-04-15 |
University Of Connecticut |
Methods for diagnosing early Lyme disease
|
|
CN1112933A
(zh)
|
1994-01-20 |
1995-12-06 |
伯伦格·曼海姆有限公司 |
抗原特异性活化t淋巴细胞，其检测和用途
|
|
US7074904B2
(en)
|
1994-07-29 |
2006-07-11 |
Altor Bioscience Corporation |
MHC complexes and uses thereof
|
|
EP0776339B2
(en)
|
1994-07-29 |
2010-01-20 |
Sunol Molecular Corporation |
Mhc complexes and uses thereof
|
|
US5635363A
(en)
|
1995-02-28 |
1997-06-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for the detection, quantitation and purification of antigen-specific T cells
|
|
US20030118594A1
(en)
*
|
1995-06-07 |
2003-06-26 |
Bishwajit Nag |
Stable formulations of mhc-peptide complexes
|
|
WO1997005239A1
(en)
|
1995-07-25 |
1997-02-13 |
Celltherapy, Inc. |
Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
|
|
US5807552A
(en)
|
1995-08-04 |
1998-09-15 |
Board Of Regents, The University Of Texas System |
Compositions for conferring immunogenicity to a substance and uses thereof
|
|
US6001964A
(en)
*
|
1995-09-20 |
1999-12-14 |
Albert Einstein College Of Medicine Of Yeshiva University |
Peptides which bind to anti-double stranded DNA antibody
|
|
US5869270A
(en)
|
1996-01-31 |
1999-02-09 |
Sunol Molecular Corporation |
Single chain MHC complexes and uses thereof
|
|
CA2250166A1
(en)
|
1996-03-28 |
1997-10-02 |
The Johns Hopkins University |
Soluble divalent and multivalent heterodimeric analogs of proteins
|
|
US6140113A
(en)
|
1996-03-28 |
2000-10-31 |
The Johns Hopkins University |
Polynucleotides encoding molecular complexes which modify immune responses
|
|
US6458354B1
(en)
|
1996-03-28 |
2002-10-01 |
The Johns Hopkins University |
Molecular complexes which modify immune responses
|
|
DK0896583T3
(da)
|
1996-05-02 |
2003-05-26 |
Dako As |
Anvendelse af peptidfragmenter fra OspC til diagnostiske metoder
|
|
WO1997044667A2
(fr)
|
1996-05-21 |
1997-11-27 |
Institut Pasteur |
Methodes d'utilisation de complexes peptide/complexe majeur d'histocompatibilite pour obtenir ou purifier des cellules t antigene-specifiques et pour stimuler des cellules t
|
|
US5846946A
(en)
|
1996-06-14 |
1998-12-08 |
Pasteur Merieux Serums Et Vaccins |
Compositions and methods for administering Borrelia DNA
|
|
US6211342B1
(en)
|
1996-07-18 |
2001-04-03 |
Children's Hospital Medical Center |
Multivalent MHC complex peptide fusion protein complex for stimulating specific T cell function
|
|
FR2751989B1
(fr)
|
1996-08-01 |
1998-10-30 |
Soc D Rech Et De Dev En Activa |
Methode d'identification de cellules eucaryotes par fixation desdites cellules sur un support et support pour mettre en oeuvre ladite methode
|
|
EP0917570A2
(en)
|
1996-08-05 |
1999-05-26 |
The President And Fellows Of Harvard College |
Mhc binding peptide oligomers and methods of use
|
|
EP0935607B1
(en)
|
1996-08-16 |
2004-07-28 |
The President And Fellows Of Harvard College |
Soluble monovalent and multivalent mhc class ii fusion proteins, and uses therefor
|
|
US20050003431A1
(en)
|
1996-08-16 |
2005-01-06 |
Wucherpfennig Kai W. |
Monovalent, multivalent, and multimeric MHC binding domain fusion proteins and conjugates, and uses therefor
|
|
US6074645A
(en)
|
1996-11-12 |
2000-06-13 |
City Of Hope |
Immuno-reactive peptide CTL epitopes of human cytomegalovirus
|
|
US6562345B1
(en)
|
1996-11-12 |
2003-05-13 |
City Of Hope |
Immuno-reactive peptide CTL epitopes of human cytomegalovirus
|
|
US6156317A
(en)
|
1996-11-12 |
2000-12-05 |
City Of Hope |
Immuno-reactive peptide CTL epitopes of human cytomegalovirus
|
|
ATE262539T1
(de)
|
1996-11-12 |
2004-04-15 |
Hope City |
Immunoreaktive peptid ctl epitope von menschlichem cytomegalovirus
|
|
US6197928B1
(en)
|
1997-03-14 |
2001-03-06 |
The Regents Of The University Of California |
Fluorescent protein sensors for detection of analytes
|
|
US5998204A
(en)
|
1997-03-14 |
1999-12-07 |
The Regents Of The University Of California |
Fluorescent protein sensors for detection of analytes
|
|
US6268411B1
(en)
|
1997-09-11 |
2001-07-31 |
The Johns Hopkins University |
Use of multivalent chimeric peptide-loaded, MHC/ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses
|
|
US5891741A
(en)
|
1997-05-16 |
1999-04-06 |
Coulter International Corp. |
Antibody-aminodextran-phycobiliprotein conjugates
|
|
US5994089A
(en)
|
1997-05-16 |
1999-11-30 |
Coulter International Corp. |
Simultaneous analyses of white blood cell subsets using multi-color, multi-intensity fluorescent markers in flow cytometry
|
|
ATE325619T1
(de)
|
1997-07-10 |
2006-06-15 |
Mannkind Corp |
Vorrichtung zur induktion einer ctl-antwort
|
|
US6248564B1
(en)
|
1997-08-29 |
2001-06-19 |
Harvard University |
Mutant MHC class I molecules
|
|
GB9718463D0
(en)
|
1997-08-29 |
1997-11-05 |
Dynal As |
Biomolecules
|
|
DK1017721T3
(da)
|
1997-09-16 |
2009-04-20 |
Univ Oregon Health & Science |
Rekombinante MHC molekyler, der kan anvendes til manipulation af antigenspecifikke T-celler
|
|
DE19740735A1
(de)
|
1997-09-16 |
1999-03-18 |
Max Planck Gesellschaft |
Arzneimittel zur Therapie einer manifesten Lyme-Borreliose
|
|
US6232445B1
(en)
|
1997-10-29 |
2001-05-15 |
Sunol Molecular Corporation |
Soluble MHC complexes and methods of use thereof
|
|
EP1029053A1
(en)
|
1997-11-10 |
2000-08-23 |
Statens Seruminstitut |
Nucleic acid fragments and polypeptide fragments derived from mycobacterium tuberculosis
|
|
AU3246399A
(en)
|
1998-01-19 |
1999-08-02 |
Florian Kern |
Method for identifying t-cell stimulating protein fragments
|
|
EP1054984A1
(en)
|
1998-02-19 |
2000-11-29 |
President And Fellows Of Harvard College |
Monovalent, multivalent, and multimeric mhc binding domain fusion proteins and conjugates, and uses therefor
|
|
WO1999050637A2
(en)
|
1998-03-27 |
1999-10-07 |
Ludwig Institute For Cancer Research |
Isolated multimeric complexes useful in analysis of t cells, peptides useful in making the complexes, and uses thereof
|
|
EP0949508A1
(en)
|
1998-04-08 |
1999-10-13 |
Dako A/S |
Method, antigen complex and kit for diagnosing Lyme borreliosis
|
|
GB9810099D0
(en)
|
1998-05-11 |
1998-07-08 |
Isis Innovation |
Novel molecule and diagnostic method
|
|
HUP0103614A2
(hu)
|
1998-05-19 |
2002-01-28 |
Avidex Limited |
Oldható T-sejt receptor
|
|
AU742626B2
(en)
|
1998-05-20 |
2002-01-10 |
Immunomedics Inc. |
Therapeutics using a bispecific anti-HLA class II invariant chain X anti-pathogen antibody
|
|
WO2000006745A1
(en)
|
1998-07-31 |
2000-02-10 |
Gundersen Lutheran Medical Foundation, Inc. |
Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine
|
|
BR9914491A
(pt)
|
1998-09-14 |
2002-01-15 |
Lars Ostergaard Pedersen |
Processo para produção de uma proteìna de superfamìlia de imunoglobulina funcional
|
|
JP2002526419A
(ja)
|
1998-10-05 |
2002-08-20 |
ファーメクサ エイ／エス |
治療上のワクチン注射のための新規な方法
|
|
AU1105700A
(en)
|
1998-10-09 |
2000-05-01 |
Med Immune, Inc. |
Decorin binding proteins dbp a and b and genes encoding them
|
|
WO2000023053A2
(en)
|
1998-10-20 |
2000-04-27 |
Salvatore Albani |
Artificial antigen-specific cells and related methods
|
|
WO2000023087A1
(en)
|
1998-10-21 |
2000-04-27 |
Sunol Molecular Corporation |
Polyspecific binding molecules and uses thereof
|
|
US6156514A
(en)
|
1998-12-03 |
2000-12-05 |
Sunol Molecular Corporation |
Methods for making recombinant cells
|
|
US7116407B2
(en)
|
1998-12-15 |
2006-10-03 |
Union Biometrica, Inc. |
System for axial pattern analysis of multicellular organisms
|
|
US6335173B1
(en)
|
1999-01-12 |
2002-01-01 |
Verve, Ltd. C/O James Bell |
Methods for detecting an analyte of interest using tyramide coating technology
|
|
US20020049302A1
(en)
|
1999-04-16 |
2002-04-25 |
Zeling Cai |
Enriched antigen-specific-cells and related therapeutic and prophylactic compositions and methods
|
|
WO2000075180A2
(de)
|
1999-06-04 |
2000-12-14 |
Florian Kern |
Peptide zur vakzinierung gegen das humane cmv
|
|
EP1683867B1
(en)
|
1999-06-18 |
2014-04-09 |
Research Foundation Of State University Of New York |
Groups of Borrelia burgdorferi and Borrelia afzelii that cause lyme disease in humans
|
|
US20040209314A1
(en)
|
1999-09-06 |
2004-10-21 |
Institut National De La Sante Et De La Recherche Medicale France |
Means for detection and purification of CD8+ T lymphocyte populations specific to peptides presented in the context of HLA
|
|
US20030104635A1
(en)
|
1999-09-21 |
2003-06-05 |
Avidex Limited |
Screening methods
|
|
GB9922352D0
(en)
|
1999-09-21 |
1999-11-24 |
Avidex Ltd |
Screening method
|
|
US6632435B1
(en)
|
1999-10-20 |
2003-10-14 |
City Of Hope |
CTL epitope analogs
|
|
US6605711B1
(en)
|
1999-11-15 |
2003-08-12 |
Ludwig Institute For Cancer Research |
NY-ESO-1 peptide derivatives, and uses thereof
|
|
DE10009341A1
(de)
|
2000-02-22 |
2001-09-06 |
Florian Kern |
Verfahren zur antigen-spezifischen Stimulation von T-Lymphozyten
|
|
US8609436B2
(en)
|
2000-03-17 |
2013-12-17 |
Guy's & St Thomas' Hospital NHS Trust (“GST”) |
Method
|
|
EP1307211A4
(en)
|
2000-03-22 |
2005-01-05 |
Corixa Corp |
IMMUNE MEDIATOR AND ASSOCIATED METHODS
|
|
US6835383B2
(en)
|
2000-03-23 |
2004-12-28 |
City Of Hope |
Protein kinase deficient, immunologically active CMVpp65 mutants
|
|
WO2001073443A2
(en)
|
2000-03-28 |
2001-10-04 |
The Government Of The United State Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Methods and compositions for the simultaneous detection of multiple analytes
|
|
WO2001080833A1
(en)
|
2000-04-20 |
2001-11-01 |
Salvatore Albani |
Methods for isolation, quantification, characterization and modulation of antigen-specific t cells
|
|
AU2001271273A1
(en)
|
2000-05-24 |
2001-12-03 |
Ludwig Institute For Cancer Research |
Multicomponent conjugates which bind to target molecules and stimulate cell lysis
|
|
AU2001261624A1
(en)
|
2000-05-25 |
2001-12-03 |
Altor Bioscience Corporation |
Modulation of t-cell receptor interactions
|
|
US6517838B1
(en)
*
|
2000-06-16 |
2003-02-11 |
The Texas A&M University System |
Decorin binding protein essential peptides and methods of use
|
|
GB0018901D0
(en)
|
2000-08-03 |
2000-09-20 |
Biovation Ltd |
Peptides presented by cells
|
|
US7132109B1
(en)
|
2000-10-20 |
2006-11-07 |
University Of Connecticut Health Center |
Using heat shock proteins to increase immune response
|
|
EP1227321A1
(en)
|
2000-12-28 |
2002-07-31 |
Institut für Bioanalytik GmbH |
Reversible MHC multimer staining for functional purification of antigen-specific T cells
|
|
US7202349B2
(en)
|
2001-01-12 |
2007-04-10 |
Becton, Dickinson And Company |
Intrinsically fluorescent, self-multimerizing MHC fusion proteins and complexes thereof
|
|
US20020082411A1
(en)
|
2001-01-23 |
2002-06-27 |
Darrick Carter |
Immune mediators and related methods
|
|
DK2336167T3
(da)
|
2001-03-14 |
2019-09-02 |
Dako Denmark As |
MHC-molekylkonstrukter og deres anvendelse til diagnose og terapi
|
|
CA2440474A1
(en)
|
2001-04-05 |
2002-10-17 |
Virginia Mason Research Center |
Methods of mhc class ii epitope mapping, detection of autoimmune t cells and antigens, and autoimmune treatment
|
|
US20030199438A1
(en)
|
2001-04-09 |
2003-10-23 |
Shaw Allan Christian |
Method for identification of proteins from intracellular bacteria
|
|
DE10117858A1
(de)
|
2001-04-10 |
2002-10-24 |
Gsf Forschungszentrum Umwelt |
MHC-Tetramere
|
|
US6811785B2
(en)
|
2001-05-07 |
2004-11-02 |
Mount Sinai School Of Medicine Of New York University |
Multivalent MHC class II—peptide chimeras
|
|
US20040143094A1
(en)
|
2003-02-10 |
2004-07-22 |
Alena Donda |
Multicomponent conjugates which bind to target molecules and stimulate T cell lysis
|
|
US20040068100A1
(en)
|
2001-05-24 |
2004-04-08 |
Jean-Pierre Mach |
Multicomponent conjugates which bind to target molecules and stimulate cell lysis
|
|
AUPR593101A0
(en)
|
2001-06-26 |
2001-07-19 |
Council Of The Queensland Institute Of Medical Research, The |
Cytomegalovirus t cell epitopes
|
|
US7902121B2
(en)
|
2001-07-02 |
2011-03-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
MHC-antigen arrays for detection and characterization of immune responses
|
|
GB0120042D0
(en)
|
2001-08-16 |
2001-10-10 |
Avidex Ltd |
Methods
|
|
WO2003073097A2
(en)
|
2002-02-28 |
2003-09-04 |
Intercell Ag |
Methods for isolating ligands e.g. t cell epitopes
|
|
US8895020B2
(en)
|
2002-04-19 |
2014-11-25 |
Washington University |
Single chain trimers and uses therefor
|
|
ATE534035T1
(de)
|
2002-05-08 |
2011-12-15 |
Northwest Biotherapeutics Inc |
Qualitätstests für antigenpräsentierende zellen
|
|
AU2003273577A1
(en)
|
2002-05-30 |
2003-12-19 |
Sloan Kettering Institute For Cancer Research |
Suicide tetramers comprising mhc class i and uses thereof
|
|
JP2005535627A
(ja)
|
2002-06-25 |
2005-11-24 |
シティ・オブ・ホープ |
アジュバント不含ペプチド・ワクチン
|
|
AU2003249778B2
(en)
|
2002-08-12 |
2010-09-23 |
The Council Of The Queensland Institute Of Medical Research |
Novel immunogenic lipopeptides comprising T-helper and cytotoxic T lymphocyte (CTL) epitopes
|
|
GB2392158B
(en)
|
2002-08-21 |
2005-02-16 |
Proimmune Ltd |
Chimeric MHC protein and oligomer thereof
|
|
GB0222846D0
(en)
|
2002-10-03 |
2002-11-06 |
Choo Yen |
Cell culture
|
|
DE10247014A1
(de)
|
2002-10-09 |
2004-04-22 |
Erfle, Volker, Prof. Priv.-Doz. Dr. |
MHC-Multimere
|
|
CA2501870C
(en)
|
2002-10-09 |
2013-07-02 |
Avidex Limited |
Single chain recombinant t cell receptors
|
|
US20040072262A1
(en)
|
2002-10-11 |
2004-04-15 |
Montero-Julian Felix A. |
Methods and systems for detecting MHC class I binding peptides
|
|
US20040223977A1
(en)
|
2003-02-03 |
2004-11-11 |
City Of Hope |
Fusion peptide HIV vaccines
|
|
DE10310261A1
(de)
|
2003-03-05 |
2004-09-23 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Identifizierung von Antigen-Epitopen
|
|
AU2004219820B2
(en)
|
2003-03-10 |
2008-06-12 |
Japan Science And Technology Agency |
Marker for detecting mesenchymal stem cell and method of distinguishing mesenchymal stem cell using the marker
|
|
US20060018878A1
(en)
|
2003-03-11 |
2006-01-26 |
City Of Hope |
Dual antigen specific T cells with trafficking ability
|
|
US20070178532A1
(en)
|
2003-03-24 |
2007-08-02 |
The Gov.Of The Us As Represented By The Secretary |
Identification, quantification, and characterization of t cells and t cell antigens
|
|
WO2004093905A1
(en)
|
2003-04-16 |
2004-11-04 |
City Of Hope |
Human cytomegalovirus antigens expressed in mva and methods of use
|
|
CA2529057A1
(en)
|
2003-06-17 |
2005-01-13 |
Mannkind Corporation |
Methods to elicit, enhance and sustain immune responses against mhc class i-restricted epitopes, for prophylactic or therapeutic purposes
|
|
JP2007525970A
(ja)
|
2003-06-27 |
2007-09-13 |
ナノスフェアー インコーポレイテッド |
バイオバーコードに基づく標的分析物の検出
|
|
WO2005007689A1
(en)
|
2003-07-11 |
2005-01-27 |
Alphavax, Inc. |
Alphavirus-based cytomegalovirus vaccines
|
|
US7364869B2
(en)
|
2003-07-29 |
2008-04-29 |
The J. David Gladstone Institutes |
Method of detecting antigen-specific T lymphocytes
|
|
GB0318096D0
(en)
|
2003-08-01 |
2003-09-03 |
Queen Mary & Westfield College |
Vaccine
|
|
GB2408507B
(en)
|
2003-10-06 |
2005-12-14 |
Proimmune Ltd |
Chimeric MHC protein and oligomer thereof for specific targeting
|
|
RU2260047C2
(ru)
|
2003-10-23 |
2005-09-10 |
Государственное учреждение Научно-исследовательский институт биохимии Сибирского отделения Российской академии медицинских наук |
Рекомбинантная плазмидная днк, обеспечивающая синтез иммунодоминантного белка borrelia garinii, используемого для диагностики лайм-боррелиоза (варианты)
|
|
WO2005047902A1
(en)
|
2003-11-03 |
2005-05-26 |
Beckman Coulter, Inc. |
Solution-based methods for detecting mhc-binding peptides
|
|
AU2004289316B2
(en)
|
2003-11-10 |
2011-03-31 |
Altor Bioscience Corporation |
Soluble TCR molecules and methods of use
|
|
DE602004019965D1
(de)
|
2003-11-19 |
2009-04-23 |
Survac Aps |
Proteine der bcl-2-familie und fragmente davon, und ihre verwendung bei krebspatienten
|
|
WO2005054860A1
(en)
|
2003-12-01 |
2005-06-16 |
Dako Denmark A/S |
Methods and compositions for immuno-histochemical detection
|
|
US7706782B1
(en)
|
2004-03-01 |
2010-04-27 |
Adobe Systems Incorporated |
System and method for developing information for a wireless information system
|
|
US20060073159A1
(en)
|
2004-05-25 |
2006-04-06 |
The Trustees Of The University Of Pennsylvania |
Human anti-cancer immunotherapy
|
|
DE102004026135A1
(de)
|
2004-05-25 |
2006-01-05 |
Immatics Biotechnologies Gmbh |
An MHC-Moleküle bindende Tumor-assoziierte Peptide
|
|
JP2008503214A
(ja)
|
2004-06-17 |
2008-02-07 |
ベックマン コールター インコーポレーティッド |
ミコバクテリウム・ツベルクローシスのエピトープ、およびその使用法
|
|
US8821893B2
(en)
|
2004-07-02 |
2014-09-02 |
Bio Peptides, Corp. |
Oral vaccine for Borrelia
|
|
US20060084116A1
(en)
|
2004-09-13 |
2006-04-20 |
Xencor, Inc. |
Analysis of MHC-peptide binding interactions
|
|
US20060228758A1
(en)
|
2004-09-13 |
2006-10-12 |
Xencor, Inc. |
Analysis of MHC-peptide binding interactions
|
|
US20060228759A1
(en)
|
2004-09-13 |
2006-10-12 |
Xencor, Inc. |
Analysis of MHC-peptide binding interactions
|
|
DE102004054545A1
(de)
|
2004-09-16 |
2006-04-06 |
Max-Delbrück-Centrum für Molekulare Medizin |
Änderung des Beladungszustandes von MHC-Molekülen
|
|
WO2006056027A1
(en)
|
2004-11-29 |
2006-06-01 |
The Council Of The Queensland Institute Of Medical Research |
Human cytomegalovirus immunotherapy
|
|
US8703142B2
(en)
|
2004-12-29 |
2014-04-22 |
Mannkind Corporation |
Methods to bypass CD4+ cells in the induction of an immune response
|
|
GB2422834B8
(en)
|
2005-02-04 |
2007-01-04 |
Proimmune Ltd |
MHC oligomer and method of making the same
|
|
JP2008528643A
(ja)
|
2005-02-04 |
2008-07-31 |
スルバック アーぺーエス |
サバイビンペプチドワクチン
|
|
EP1851545B1
(en)
|
2005-02-25 |
2014-12-31 |
Dako Denmark A/S |
Cell counting
|
|
KR100677572B1
(ko)
|
2005-04-04 |
2007-02-02 |
삼성전자주식회사 |
전자사진방식 화상형성장치 및 현상방법
|
|
WO2006113622A2
(en)
|
2005-04-15 |
2006-10-26 |
University Of Maryland, Baltimore |
Direct vaccination of the bone marrow
|
|
US8481697B2
(en)
|
2005-07-01 |
2013-07-09 |
Dako Denmark A/S |
Nucleic acid base pairs
|
|
US7468186B2
(en)
|
2005-07-22 |
2008-12-23 |
City Of Hope |
Polyomavirus cellular epitopes and uses therefor
|
|
WO2007065098A2
(en)
|
2005-11-29 |
2007-06-07 |
Virginia Commonwealth University |
Polyvalent chimeric ospc vaccinogen and diagnostic antigen
|
|
US7502580B2
(en)
|
2005-11-30 |
2009-03-10 |
Xerox Corporation |
Two component development system using ion or electron charged toner
|
|
US20070134814A1
(en)
|
2005-12-09 |
2007-06-14 |
Kajander E O |
Methods and compositions for the detection of calcifying nano-particles, identification and quantification of associated proteins thereon, and correlation to disease
|
|
EP1982176A1
(en)
|
2006-01-30 |
2008-10-22 |
Dako Denmark A/S |
High-speed quantification of antigen specific t-cells in whole blood by flow cytometry
|
|
US8518697B2
(en)
|
2006-04-04 |
2013-08-27 |
Washington University |
Single chain trimers and uses therefor
|
|
WO2007136778A2
(en)
|
2006-05-19 |
2007-11-29 |
Teva Pharmaceutical Industries, Ltd. |
Fusion proteins, uses thereof and processes for producing same
|
|
WO2008019366A2
(en)
|
2006-08-07 |
2008-02-14 |
Ludwig Institute For Cancer Research |
Methods and compositions for increased priming of t-cells through cross-presentation of exogenous antigens
|
|
EP2059526A2
(en)
|
2006-09-15 |
2009-05-20 |
Intercell AG |
Borrelia antigens
|
|
EP2155782A2
(en)
|
2007-03-26 |
2010-02-24 |
Dako Denmark A/S |
Mhc peptide complexes and uses thereof in infectious diseases
|
|
US20090004213A1
(en)
|
2007-03-26 |
2009-01-01 |
Immatics Biotechnologies Gmbh |
Combination therapy using active immunotherapy
|
|
EP3620465B1
(en)
|
2007-07-03 |
2025-02-19 |
Dako Denmark A/S |
Improved methods for generation, labeling and use of mhc multimers
|
|
US10611818B2
(en)
|
2007-09-27 |
2020-04-07 |
Agilent Technologies, Inc. |
MHC multimers in tuberculosis diagnostics, vaccine and therapeutics
|
|
WO2009106073A2
(en)
|
2008-02-28 |
2009-09-03 |
Dako Denmark A/S |
Mhc multimers in borrelia diagnostics and disease
|
|
MX2010010034A
(es)
|
2008-03-14 |
2010-12-06 |
Sanofi Pasteur Biologics Co |
Vacunas de flavivirus defectuosas en replicacion y vectores de vacunas.
|
|
JP2011518553A
(ja)
|
2008-04-09 |
2011-06-30 |
カリフォルニア インスティチュート オブ テクノロジー |
標的を検出及び／又は分類する捕捉剤および関連する方法およびシステム
|
|
US20110117131A1
(en)
|
2008-04-09 |
2011-05-19 |
Ning Huang |
Production of OspA for Lyme Disease Control
|
|
US8435538B2
(en)
|
2008-04-10 |
2013-05-07 |
Thrombosis Research Institute |
Anti-atheroma vaccine
|
|
US20090324630A1
(en)
|
2008-04-21 |
2009-12-31 |
Jensen Michael C |
Fusion multiviral chimeric antigen
|
|
FR2931163B1
(fr)
|
2008-05-16 |
2013-01-18 |
Ets Francais Du Sang |
Lignee de cellules dendritiques plasmacytoides utilisee en therapie cellulaire active ou adoptive
|
|
EP3156069B8
(en)
|
2008-06-20 |
2020-10-21 |
Duke University |
Compositions, methods, and kits for eliciting an immune response
|
|
WO2010009735A2
(en)
|
2008-07-23 |
2010-01-28 |
Dako Denmark A/S |
Combinatorial analysis and repair
|
|
GB0817244D0
(en)
|
2008-09-20 |
2008-10-29 |
Univ Cardiff |
Use of a protein kinase inhibitor to detect immune cells, such as T cells
|
|
US20110318380A1
(en)
|
2008-10-01 |
2011-12-29 |
Dako Denmark A/S |
MHC Multimers in Cancer Vaccines and Immune Monitoring
|
|
WO2010037397A1
(en)
|
2008-10-01 |
2010-04-08 |
Dako Denmark A/S |
Mhc multimers in cmv immune monitoring
|
|
WO2010037402A1
(en)
|
2008-10-02 |
2010-04-08 |
Dako Denmark A/S |
Molecular vaccines for infectious disease
|